180 related articles for article (PubMed ID: 20469685)
1. [Efficiency of ursotherapy in cholesterol-associated pathology of the gallbladder].
Il'chenko AA; Drozhzhina IuV
Eksp Klin Gastroenterol; 2009; (8):96-101. PubMed ID: 20469685
[TBL] [Abstract][Full Text] [Related]
2. [Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis].
Il'chenko AA; Drozhzhina IuV
Eksp Klin Gastroenterol; 2007; (5):29-34, 164. PubMed ID: 18389594
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
[TBL] [Abstract][Full Text] [Related]
4. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
Miettinen TE; Tarpila S; Gylling H
Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
[TBL] [Abstract][Full Text] [Related]
5. Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans.
Lanzarotto F; Panarotto B; Sorbara R; Panteghini M; Pagani F; Sosta S; Lanzini A
Gut; 1999 Apr; 44(4):552-6. PubMed ID: 10075964
[TBL] [Abstract][Full Text] [Related]
6. [Significance of biliary dysfunction in the pathogenesis of gallstone disease].
Il'chenko IA; Deliukina OV
Eksp Klin Gastroenterol; 2011; (7):70-8. PubMed ID: 22364003
[TBL] [Abstract][Full Text] [Related]
7. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T
Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
[TBL] [Abstract][Full Text] [Related]
8. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
[TBL] [Abstract][Full Text] [Related]
9. Biliary microlithiasis in patients with idiopathic acute pancreatitis and unexplained biliary pain: response to therapy.
Saraswat VA; Sharma BC; Agarwal DK; Kumar R; Negi TS; Tandon RK
J Gastroenterol Hepatol; 2004 Oct; 19(10):1206-11. PubMed ID: 15377301
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of ursodeoxycholic acid in cholesterosis of the gallbladder].
I'lchenko AA; Orlova IuN
Ter Arkh; 2003; 75(2):35-8. PubMed ID: 12685388
[TBL] [Abstract][Full Text] [Related]
11. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE
Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of ursodeoxycholic acid in gallbladder cholesterosis accompanied by cholecystolithiasis].
Il'chenko AA; Orlova IuN
Eksp Klin Gastroenterol; 2003; (1):46-50, 182. PubMed ID: 12664784
[TBL] [Abstract][Full Text] [Related]
13. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis.
Bonnand AM; Heathcote EJ; Lindor KD; Poupon RE
Hepatology; 1999 Jan; 29(1):39-43. PubMed ID: 9862847
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic recurrent pancreatitis: long-term results after ERCP, endoscopic sphincterotomy, or ursodeoxycholic acid treatment.
Testoni PA; Caporuscio S; Bagnolo F; Lella F
Am J Gastroenterol; 2000 Jul; 95(7):1702-7. PubMed ID: 10925971
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments.
Miettinen TE; Kiviluoto T; Taavitsainen M; Vuoristo M; Miettinen TA
Hepatology; 1998 Mar; 27(3):649-55. PubMed ID: 9500689
[TBL] [Abstract][Full Text] [Related]
17. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ursodeoxycholic acid in primary, type IIa or IIb hypercholesterolemia: a multicenter, randomized, double-blind clinical trial.
Braga MF; Grace MG; Lenis J; Kennedy FP; Teplinsky AL; Roederer G; Palumbo PJ; Colin P; Leiter LA
Atherosclerosis; 2009 Apr; 203(2):479-82. PubMed ID: 18801487
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis].
Avezov SA; Mansurova FKh
Klin Med (Mosk); 2004; 82(2):46-9. PubMed ID: 15106512
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis].
Avezov SA; Mansurov FKh
Klin Med (Mosk); 2004; 82(3):55-8. PubMed ID: 15114777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
